SCHEMBL21741963

SCHEMBL21741963

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc5oc6ccc(-c7ccc8c9ccccc9c9ccccc9c8c7)cc6c45)n3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.42
PLA2G4A P47712 4/20 0.42
PLA2G10 O15496 1/20 0.40
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
MAPT P10636 3/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20392082 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL21741830 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL21741739 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL19802959 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL23138587 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL24840885 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL19802936 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL25586900 0.97 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL26287139 0.97 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2
SCHEMBL22876471 0.97 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-01-18 US disclosed
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-01-18 US disclosed
EP-4276924-A1 ORGANIC LIGHT EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-11-15 EP disclosed
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 US disclosed
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 US disclosed
US-11800730-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-10-24 US disclosed
US-11800730-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-10-24 US disclosed
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-21 US disclosed
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-21 US disclosed
EP-4243100-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-09-13 EP disclosed
WO-2022086296-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 WO disclosed
WO-2022086297-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 WO disclosed
EP-3972001-A1 ORGANIC LIGHT EMITTING DEVICE LG Chem, Ltd. (KR) 2022-03-23 EP disclosed
US-11251377-B2 Organic light emitting device LG CHEM, LTD. (KR) 2022-02-15 US disclosed
WO-2022015084-A1 ORGANIC LIGHT-EMITTING ELEMENT 주식회사 엘지화학 2022-01-20 WO disclosed
WO-2021230715-A1 ORGANIC LIGHT-EMITTING ELEMENT 주식회사 엘지화학 2021-11-18 WO disclosed
WO-2021182893-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2021-09-16 WO disclosed
US-20210009894-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-14 US disclosed
US-20200058877-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2020-02-20 US disclosed
EP-3348625-A1 ORGANIC LIGHT-EMITTING DEVICE LG Chem, Ltd. (KR) 2018-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, CYP1A1 PLA2G2A 2723/4885PLA2G4A 3014/4885PLA2G10 3509/4885
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, PER2 PLA2G2A 2843/4885PLA2G4A 3267/4885PLA2G10 2576/4885
US-11800730-B2 Organic light emitting device CRY1, CRY2, MAP1LC3C PLA2G2A 1705/4885PLA2G4A 2120/4885PLA2G10 3644/4885
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, CYP1A1 PLA2G2A 3903/4885PLA2G4A 4050/4885PLA2G10 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.